Markets
Will the AI-discovered natural molecule receive FDA approval by July 2027?
Yes0%No0%
Loading...
About this market
This market resolves to Yes if the AI-discovered natural molecule identified by Stanford scientists as having Ozempic-like effects without typical side effects receives FDA approval by July 31, 2027. The market resolves to No if approval has not been granted by this date.
Rules
- Market closes at 7/31/2027.
- Logic weighted resolution applies.
I find it hard to believe this natural molecule will get FDA approval by July 2027. Sure, AI can uncover new compounds, but the approval process is notoriously slow and complicated. Plus, the FDA is extremely cautious when it comes to anything that could impact public health. The price reflects optimism but I think it is miscalculated; we might be looking at a much longer timeline.
Rationale:The comment presents a reasonable skepticism about the FDA approval timeline, supported by the known complexities of the approval process. It avoids logical fallacies and remains relevant to the market question. The weights reflect a balanced emphasis on factual accuracy and logical reasoning, given the comment's focus on the approval process and its implications for the market.
The market is pricing in a 65% chance of FDA approval, but based on previous approvals for similar AI-discovered compounds, I'd estimate closer to 45% given the regulatory complexities. There is always a risk of unexpected roadblocks in clinical trials. Have there been any recent updates on the trial results that could sway this?
Rationale:The comment provides a reasonable estimate of FDA approval chances based on historical data, which is mostly accurate but lacks specific evidence for the 45% figure. It avoids logical fallacies and is relevant to the market question, discussing regulatory complexities and the potential for roadblocks. The weights reflect a balanced focus on factual accuracy and logical reasoning, given the speculative nature of the approval process.
tbh, i think this is way optimistic. sure, AI found the molecule but getting FDA approval takes time. i'm thinking more like 2028, especially with all the red tape.
Rationale:The comment presents a reasonable skepticism regarding the timeline for FDA approval, which is a valid concern given the complexities of the approval process. While it lacks specific data to support the claim about the timeline extending to 2028, it does not contain logical fallacies and is relevant to the market question. The weights reflect a balance between the need for factual accuracy and the logical reasoning behind the opinion expressed.
The current odds seem way too high given the typical timelines for FDA reviews, especially for something new like this; I'd bet against it.
Rationale:The comment provides a reasonable perspective on the FDA review timelines, which is relevant to the market question. However, it lacks specific data to fully support the claim about the odds being too high, leading to a score of 70 for Fact Check. The comment is mostly free of logical fallacies and directly addresses the market outcome, but it does contain some emotional appeal regarding betting against the approval. The weights reflect the importance of relevance and logical reasoning in this context.
tbh, I think this market is way too optimistic; there's always complications with FDA approvals and this molecule's not even on anyone's radar yet. like, I get the hype around AI, but just because it was discovered by a machine doesn't mean it’s a slam dunk.
Rationale:The comment presents a mostly accurate perspective on the challenges of FDA approvals, though it lacks specific evidence regarding the molecule's current status. It addresses the market question directly, highlighting skepticism about the optimism surrounding AI discoveries. The weights reflect a balance between relevance and the need for logical reasoning, given the comment's speculative nature about the FDA process and the molecule's visibility.
why is the market so optimistic about this? we’ve seen a million compounds fail for every one that actually gets approved, and now we’re suddenly trusting some AI to save the day? sounds kinda sketchy if you ask me.
Rationale:The comment raises valid concerns about the optimism surrounding AI-discovered compounds, referencing the historical failure rate of drug approvals. However, it lacks specific data to support the skepticism about AI's role, leading to a score of 70 for Fact Check. The argument is mostly logical with some emotional appeal, hence the balanced scores in No Fallacies and Logic/Emotion. The weights reflect the importance of relevance and logical consistency in this context.
nah, this feels like a stretch, like the FDA has been slow af with approvals lately and this is a brand new thing, can’t see them rushing it.
Rationale:The comment expresses skepticism about the FDA's speed in approving new substances, which is a relevant concern for the market question. While it accurately reflects a general sentiment about FDA approval timelines, it lacks specific evidence to support the claim about the molecule's approval. The comment is mostly logical but contains some emotional language, leading to a balanced score across the criteria. The weights reflect the importance of relevance and logical reasoning in this context.
too risky at this price, FDA approvals take forever and this is a new area.
Rationale:The comment accurately reflects the general perception that FDA approvals can be lengthy, especially in new areas, but lacks specific evidence or data to support the claim about the current price being too risky. It is relevant to the market question, discussing the risks associated with FDA approval timelines. The weights reflect a balance between factual accuracy and logical reasoning, with a slight emphasis on relevance due to the comment's focus on risk assessment.
ngl, this market feels kinda off. like, sure, AI can find cool stuff, but getting FDA approval is brutal. i’d say it's more likely to miss that July 2027 deadline, maybe like 60% chance? i dunno, just seems optimistic for something that has to go through all that red tape.
Rationale:The comment expresses skepticism about the likelihood of FDA approval by July 2027, which is relevant to the market question. However, it lacks specific factual support for the claim about the approval process and the estimated probability. The weights reflect a balance between the need for factual accuracy and the relevance of the comment's content. Overall, the comment is mostly logical but leans on emotional skepticism without strong evidence.
honestly, why are we even debating this? if it was so groundbreaking, wouldn't it already be approved? the price feels a little too optimistic for something that could still be stuck in trials.
Rationale:The comment raises valid points about the approval process and the optimism surrounding the price, but it lacks specific factual references to support its claims about the molecule's status. The reasoning is somewhat emotional, questioning the validity of the debate without providing substantial evidence. The weights reflect a balance between relevance and the need for factual accuracy, given the speculative nature of the comment.